Colestipol Hydrochloride Patent Expiration

Colestipol Hydrochloride was first introduced by Pfizer Inc in its drug Flavored Colestid on Approved Prior to Jan 1, 1982. Another drug containing Colestipol Hydrochloride is Colestid. 4 different companies have introduced drugs containing Colestipol Hydrochloride.


Colestipol Hydrochloride Patents

Given below is the list of patents protecting Colestipol Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Colestid US5490987 Tableting of colestipol hydrochloride Feb 13, 2013

(Expired)

Pfizer



Colestipol Hydrochloride Generics

Several generic applications have been filed for Colestipol Hydrochloride. The first generic version for Colestipol Hydrochloride was by Impax Laboratories Inc and was approved on May 2, 2006. And the latest generic version is by Ani Pharmaceuticals Inc and was approved on Mar 10, 2023.

Given below is the list of companies who have filed for Colestipol Hydrochloride generic.


1. ANI PHARMS

Ani Pharmaceuticals Inc has filed for 1 generic for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Ani Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM tablet Prescription ORAL AB Mar 10, 2023


2. IMPAX LABS

Impax Laboratories Inc has filed for 3 different strengths of generic version for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Impax Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5GM/SCOOPFUL granule Prescription ORAL AB May 2, 2006
5GM/PACKET granule Prescription ORAL AB May 2, 2006
1GM

(reference standard)

tablet Prescription ORAL AB Oct 24, 2006


3. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Colestipol Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
1GM tablet Prescription ORAL AB Mar 10, 2022